2018
DOI: 10.1016/j.dld.2018.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Myogenic oxidative imbalance interferes with antral motility in obese subjects

Abstract: Antral myogenic activity of obese subjects can be impaired by alterations of signaling pathways induced by oxidative stress.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 30 publications
0
0
0
Order By: Relevance
“…In this context, a recent study shows that DD patients' diet has a lower antioxidant content and a reduced oxygen radical absorbance capacity than healthy subjects 44 . Further, in ex‐vivo human models, antioxidants have been shown to revert the oxidative‐driven switch of SMCs to a synthetic myofibroblast‐like phenotype induced by LPS 39 and to improve impaired human antrum relaxation in obese patients 45 . Therefore, antioxidant supplementation may counteract disease progression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this context, a recent study shows that DD patients' diet has a lower antioxidant content and a reduced oxygen radical absorbance capacity than healthy subjects 44 . Further, in ex‐vivo human models, antioxidants have been shown to revert the oxidative‐driven switch of SMCs to a synthetic myofibroblast‐like phenotype induced by LPS 39 and to improve impaired human antrum relaxation in obese patients 45 . Therefore, antioxidant supplementation may counteract disease progression.…”
Section: Discussionmentioning
confidence: 99%
“…44 Further, in ex-vivo human models, antioxidants have been shown to revert the oxidative-driven switch of SMCs to a synthetic myofibroblast-like phenotype induced by LPS 39 and to improve impaired human antrum relaxation in obese patients. 45 Therefore, antioxidant supplementation may counteract disease progression. Furthermore, the recent demonstration that circulating serological markers reflect tissue oxidative imbalance in the different clinical phenotypes of DD 37 provides a valuable tool to monitor disease progression and validate targeted therapeutic strat-…”
Section: Discussionmentioning
confidence: 99%